We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Get help to classify pharmaceutical products used to treat or prevent diseases or ailments (in humans or animals), including comparators used in clinical trials and placebos.
A range of factsheets introducing the work of the Trade Remedies Authority (TRA) and how you can work with us when applying for trade remedies.
The Charity Commission concludes its inquiry into The Kingdom Church GB and bans preacher for 15 years.
Every local authority across England to be allocated additional funding to help combat drug and alcohol misuse.
How to comply with the exemption from the Veterinary Medicines Regulations that allow certain animal medicines to be sold without a marketing authorisation.
A 10-year plan to cut crime and save lives by reducing the supply and demand for drugs and delivering a high-quality treatment and recovery system.
This document sets out the government's vision for putting prevention at the heart of the nation's health.
Explainer for businesses and persons regulated by the Veterinary Medicines Regulations 2013, as amended, on the transitional provisions included in the amending legislation: the Veterinary Medicines (Amendment etc.) Regulations 2024.
The Medicines and Healthcare products Regulatory Agency (MHRA) has today (9 April 2024) approved the medicine fosdenopterin (Nulibry) to treat the genetic disease Molybdenum Cofactor Deficiency (MoCD) Type A
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Guidance for prescribing vets on the use of the cascade.
The actions to take for sourcing medicines in different circumstances.
Patients with severe alopecia areata (patchy hair loss) could access a new medicine to help treat their condition.
How traditional herbal medicines and homeopathic medicines will be treated by the MHRA.
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
This guidance provides information on comparator products used in studies supporting abridged marketing authorisation applications
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).